0001 - nitric oxide therapy services

Ended Awarded Last action

Contract number
W81K0221F0023
Awardee
Awarding agency
Obligated
$232,772

Award facts

Opportunity
Contract value 100% obligated
$232,772.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
LEWIS MCCHORD, WA 98431, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00014 · Nitric oxide therapy service -$62,746
Funding Only Action P00013 · Nitric oxide therapy service - obligate FY25 funding $125,655
Other Administrative Action P00012 · Nitric oxide therapy service - P00012- deob FY24 -$60,000
Exercise an Option P00011 · 4001 - nitric oxide therapy service EX OY4 $0
Funding Only Action P00010 · Modification - funding - 3001 - nitric oxide therapy service $125,655
Exercise an Option P00009 · Modification - option 3 exercise - nitric oxide therapy service $0
Supplemental Agreement for work within scope P00008 · Nitric oxide therapy service - deob -$135,572
Supplemental Agreement for work within scope P00007 · Nitric oxide therapy services - price change and FY23 funding $63,700
Exercise an Option P00006 · Nitric oxide therapy service - exercise option 2 $0
Supplemental Agreement for work within scope P00005 · Nitric oxide therapy services - update & apply decrease in pricing change based on VA GSA schedule -$43,816
Funding Only Action P00004 · 1001 - nitric oxide therapy services - FY 22 funding $125,655
Exercise an Option P00003 · 1001 - nitric oxide therapy services $0
Supplemental Agreement for work within scope P00002 $0
Funding Only Action P00001 $94,241
Original award $0
Show all 15

About this award

This is a firm-fixed price delivery order contract awarded by the Defense Health Agency to INO Therapeutics LLC, a foreign-owned, for-profit organization that specializes in providing inhaled nitric oxide therapy systems and related medical gases to federal government healthcare agencies. The contract is for Nitric Oxide Therapy Services, with a ceiling value of $232,772.44 and a period of performance through September 30, 2025.

The contract is not set aside and was issued under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). INO Therapeutics LLC is a prime contractor that has been awarded multiple federal contracts by the Department of Veterans Affairs (VA) and the Defense Health Agency to supply nitric oxide gas, delivery systems, and respiratory therapy services to support medical treatments for veterans, service members, and military beneficiaries. The company currently holds three significant federal contract Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles, including a Blanket Purchase Agreement with the Defense Health Agency for inhaled nitric oxide therapeutic gas.

Quick answers

Who was awarded contract W81K0221F0023?

W81K0221F0023 was awarded to INO Therapeutics LLC by Medical Command (Department of the Army) on January 1, 2021.

How much is contract W81K0221F0023 worth?

The government has obligated $232,772 on W81K0221F0023.

Which agency awarded contract W81K0221F0023?

Medical Command (Department of the Army) awarded W81K0221F0023, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0221F0023 an order under another contract?

Yes. W81K0221F0023 is a delivery order under V797D60737, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract W81K0221F0023 competed?

The extent of competition for W81K0221F0023 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award